Key Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| Q2 2026 | ~2026-06-30 | $1.7300 |
| Q1 2026 | ~2026-03-31 | $1.7300 |
| Q1 2025 | ~2025-12-31 | $1.7300 |
| Q3 2025 | ~2025-09-30 | $1.6400 |
| Q2 2025 | ~2025-06-30 | $1.6400 |
| Q1 2025 | ~2025-03-31 | $1.6400 |
| Q1 2024 | ~2024-12-31 | $1.6400 |
| Q1 2024 | ~2024-09-30 | $1.5500 |
| Q1 2024 | ~2024-06-30 | $1.5500 |
| Q1 2024 | ~2024-03-31 | $1.5500 |
| Q4 2022 | ~2022-12-09 | $1.4800 |
| Q3 2022 | ~2022-09-09 | $1.4100 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
AbbVie is a global, diversified research-based biopharmaceutical company with a mission to discover and deliver innovative medicines and solutions that solve serious health issues… today and address the medical challenges of tomorrow. AbbVie is positioned for success with a comprehensive product portfolio that has leadership positions across immunology, neuroscience, oncology, and aesthetics. The company's products help patients and customers in more than 180 countries and territories around the world. Since inception, AbbVie has invested over $85 billion to research, develop, and discover new medicines and solutions. The company operates through multiple therapeutic segments and has a strong commitment to innovation, quality, compliance, safety, and performance. With approximately 57,000 employees worldwide driven by compassion for people, commitment to innovation and inclusion, and service to the community, AbbVie is focused on making a remarkable impact for patients, communities, and stakeholders.
- Name
- AbbVie Inc.
- Industry
- Drug Manufacturers - General
- CEO
- Robert A. Michael · Chairman of the Board and Chief Executive Officer
- Employees
- 57,000 as of 2025-12-31
- IPO Date
- 2017-03-02
- Phone
- (847) 932-7900
- Address
- 1 North Waukegan Road, North Chicago, IL 60064
- Website
- www.abbvie.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Azita Saleki-Gerhardt | — | — |
| Jeffrey R. Stewart | — | — |
| Roopal B. Thakkar | — | — |
| Scott T. Reents | Chief Financial Officer | — |
| Robert A. Michael | Chairman of the Board and Chief Executive Officer | — |
Latest News
-
2026-04-26
Axecap Investments LLC Increases Stock Position in AbbVie Inc. $ABBV defenseworld.net
- 2026-04-26
-
2026-04-25
Calamos Advisors LLC Grows Stock Holdings in AbbVie Inc. $ABBV defenseworld.net
- 2026-04-24
- 2026-04-24
-
2026-04-24
10 Dividend Growth Stocks: April 2025 seekingalpha.com
- 2026-04-23
- 2026-04-23